LeadIQ logo
Learn more at LeadIQ.com

Insights

Global Expansion AmbioPharm's recent investment of $28 million in expanding its Shanghai manufacturing facility presents significant growth opportunities for suppliers and partners specializing in Asian manufacturing ecosystems, equipment, and local logistics services.

Leadership Growth The appointment of a seasoned industry veteran as CEO and the addition of a Chief Commercial Officer suggest a strategic focus on expanding global client relationships and increasing sales efforts within the peptide CDMO market segment.

Strategic Partnerships Collaborations with biotech firms like CombiGene and Ariceum highlight AmbioPharm's openness to joint development projects, providing opportunities for vendors offering innovative peptide conjugates, research materials, and specialized manufacturing services.

Market Positioning With a revenue range of $50M to $100M and multiple FDA-inspected facilities, AmbioPharm is positioned as a reliable contract manufacturer, opening opportunities for sales of high-quality cGMP raw materials, quality testing services, and regulatory consulting.

Innovation Focus AmbioPharm's specialization in developing efficient manufacturing processes for peptide APIs at various scales suggests potential for partnerships with technology providers offering advanced manufacturing equipment, process optimization tools, and automation solutions to enhance production efficiency.

Similar companies to AmbioPharm - A Global Peptide CDMO

AmbioPharm - A Global Peptide CDMO Tech Stack

AmbioPharm - A Global Peptide CDMO uses 8 technology products and services including Termly, React, imagesLoaded, and more. Explore AmbioPharm - A Global Peptide CDMO's tech stack below.

  • Termly
    Cookie Compliance
  • React
    Javascript Frameworks
  • imagesLoaded
    Javascript Libraries
  • Moment.js
    Javascript Libraries
  • Microsoft Project
    Project Management
  • Bootstrap
    UI Frameworks
  • X-Content-Type-Options
    Web & Portal Technology
  • Apache
    Web Servers

Media & News

AmbioPharm - A Global Peptide CDMO's Email Address Formats

AmbioPharm - A Global Peptide CDMO uses at least 1 format(s):
AmbioPharm - A Global Peptide CDMO Email FormatsExamplePercentage
First.Last@ambiopharm.comJohn.Doe@ambiopharm.com
94%
Last@ambiopharm.comDoe@ambiopharm.com
4%
FLast@ambiopharm.comJDoe@ambiopharm.com
2%

Frequently Asked Questions

Where is AmbioPharm - A Global Peptide CDMO's headquarters located?

Minus sign iconPlus sign iconAmbioPharm - A Global Peptide CDMO's main headquarters is located at 1024 Dittman Court Clearwater, South Carolina 29842 United States. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is AmbioPharm - A Global Peptide CDMO's phone number?

Minus sign iconPlus sign icon You can contact AmbioPharm - A Global Peptide CDMO's main corporate office by phone at
+1-408-832-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is AmbioPharm - A Global Peptide CDMO's official website and social media links?

Minus sign iconPlus sign iconAmbioPharm - A Global Peptide CDMO's official website is ambiopharm.com and has social profiles on LinkedInCrunchbase.

How much revenue does AmbioPharm - A Global Peptide CDMO generate?

Minus sign iconPlus sign icon As of March 2026, AmbioPharm - A Global Peptide CDMO's annual revenue is estimated to be $4.6M.

What is AmbioPharm - A Global Peptide CDMO's SIC code NAICS code?

Minus sign iconPlus sign iconAmbioPharm - A Global Peptide CDMO's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does AmbioPharm - A Global Peptide CDMO have currently?

Minus sign iconPlus sign iconAs of March 2026, AmbioPharm - A Global Peptide CDMO has approximately 164 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Executive Officer, Board Member: B. G.Chief Executive Officer: A. L.Chief Commercial Officer (cco): T. P. W.. Explore AmbioPharm - A Global Peptide CDMO's employee directory with LeadIQ.

What industry does AmbioPharm - A Global Peptide CDMO belong to?

Minus sign iconPlus sign iconAmbioPharm - A Global Peptide CDMO operates in the Pharmaceutical Manufacturing industry.

What technology does AmbioPharm - A Global Peptide CDMO use?

Minus sign iconPlus sign iconAmbioPharm - A Global Peptide CDMO's tech stack includes TermlyReactimagesLoadedMoment.jsMicrosoft ProjectBootstrapX-Content-Type-OptionsApache.

What is AmbioPharm - A Global Peptide CDMO's email format?

Minus sign iconPlus sign iconAmbioPharm - A Global Peptide CDMO's email format typically follows the pattern of First.Last@ambiopharm.com. Find more AmbioPharm - A Global Peptide CDMO email formats with LeadIQ.

When was AmbioPharm - A Global Peptide CDMO founded?

Minus sign iconPlus sign iconAmbioPharm - A Global Peptide CDMO was founded in 2005.

AmbioPharm - A Global Peptide CDMO

Pharmaceutical ManufacturingSouth Carolina, United States51-200 Employees

AmbioPharm, a global peptide CDMO, was founded in 2005 and is headquartered in North Augusta, South Carolina, USA specializing in developing highly efficient manufacturing processes for peptide-based Active Pharmaceutical Ingredients (APIs) at small to very large scales. In our manufacturing facilities in South Carolina, USA and Shanghai, China, we manufacture New Chemical Entities (NCEs) under cGMP for clients worldwide. Both facilities have been inspected multiple times by the FDA with excellent outcomes.

Section iconCompany Overview

Headquarters
1024 Dittman Court Clearwater, South Carolina 29842 United States
Phone number
+1-408-832-****
Website
ambiopharm.com
SIC Code
2834 - Pharmaceutical Preparations
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2005
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $50M$100M

    AmbioPharm - A Global Peptide CDMO's revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $50M$100M

    AmbioPharm - A Global Peptide CDMO's revenue is estimated to be in the range of $50M$100M

Company Leadership

  • Stylized image of a person
    B. G.
    Chief Executive Officer, Board Member
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. L.
    Chief Executive Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    T. P. W.
    Chief Commercial Officer (cco)
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. P.
    Chief Scientific Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. B.
    Vice President Of Accounting
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    M. B.
    Vice President Of Accounting
    Phone icon
    Mobile Phone
  • Stylized image of a person
    N. S.
    Vp Of Sales
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. B.
    Vp Of Project Management
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. L. C.
    Vp Of Finance And Hr
    Phone icon
    Mobile Phone
  • Stylized image of a person
    K. N.
    Vice President Sales Europe
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.